Warm sunshine feels so good on the skin, but over your lifetime the cumulative effects of long-term sun exposure and other sources of ultraviolet light can lead to basal cell carcinoma (BCC). Nearly three million Americans are diagnosed with BCC each year—making it the most common type of all cancers. With the number of cases expected to grow, more people will undergo basal cell carcinoma treatment. Although it is the mildest form of skin cancer and rarely spreads to vital organs, rare aggressive forms of the disease can be deadly if not treated properly.
For years, traditional basal cell carcinoma treatment—including Mohs—has involved invasive cutting through healthy tissue, painful healing, lengthy recovery and unsightly scarring. Sensus Healthcare is changing all that with a non-surgical treatment option—the SRT-100™
Now patients undergoing basal cell carcinoma treatment don’t have to worry about permanent disfigurement, nerve damage or injury to muscles.
The SRT-100™ delivers a precise, calibrated dose of Superficial Radiotherapy (SRT) that only penetrates five millimeters below the skin’s surface. This gentle Squamous Cell Carcinoma treatment effectively destroys cancer cells without cutting, bleeding, stitching or scarring.
Performed right in the doctor’s office, Squamous Cell Carcinoma treatment with the SRT-100™ is painless. Patients usually undergo a series of treatments. The SRT-100™ delivers optimum results—a 95 percent cure rate for non-melanoma skin cancer. Best of all, patients don’t need reconstructive plastic surgery afterward.
The SRT-100™ can be used to remove Squamous Cell Carcinoma anywhere on the body. It works especially well on SCC located on the face, lower lip, rim of the ear, balding scalp, neck, hands, arms and legs.
Non Reoccurrence Rate
No anesthesia, cutting, bleeding, stitching or pain
No downtime or lifestyle restrictions
Super cosmesis, no unsightly scarring
No need for post-treatment reconstructive surgeries